In the not-too-distant future, the CBD or THC you consume when you swallow an infused edible or tincture may not be derived from cannabis at all. Your daily dose of cannabinoids might be grown in a laboratory instead of a greenhouse.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as “focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants.”
Comments
Comments are disabled for this post.